Save Stocks
Viewing
Filtered By
Ordered By
UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog
1/22/2015 7:00:00 PM - Zacks.com


UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog
1/22/2015 7:00:00 AM - Investopedia


Immunomedics Reports Data on Oncology Candidate - Analyst Blog
1/21/2015 4:05:00 PM - Zacks.com


Immunomedics Reports Data on Oncology Candidate - Analyst Blog
1/21/2015 4:05:00 AM - Investopedia


UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog
1/19/2015 2:10:00 PM - Investopedia


UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog
1/19/2015 2:10:00 PM - Zacks.com


UCB Initiates Phase III Psoriasis Study on Cimzia with Dermira - Analyst Blog
1/9/2015 5:05:00 PM - Zacks.com


UCB Initiates Phase III Psoriasis Study on Cimzia with Dermira - Analyst Blog
1/9/2015 5:05:00 AM - Investopedia


Immunomedics: Under-Followed Company With Robust Pipeline And Huge Growth Potential
12/26/2014 5:17:00 PM - Seeking Alpha


UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog
12/18/2014 3:20:00 PM - Zacks.com


UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog
12/18/2014 3:20:00 AM - Investopedia


UCB Reports Phase III Data on Epilepsy Drug, To File in 2015 - Analyst Blog
12/9/2014 2:50:00 PM - Zacks.com


UCB Presents Primary Study Results From Latest Phase 3 Brivaracetam Study
12/8/2014 1:13:00 AM - RTT News


UCB-Daiichi Sankyo Ink Deal to Sell Vimpat in Japan - Analyst Blog
12/1/2014 3:20:00 PM - Zacks.com


Immunomedics' Veltuzumab Receives Orphan Drug Status - Analyst Blog
11/24/2014 4:20:00 PM - Zacks.com


Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
11/19/2014 1:00:00 AM - Zacks.com


Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
11/19/2014 1:00:00 AM - Zacks.com


Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
11/18/2014 1:00:00 PM - Investopedia


Will Catalyst Pharmaceuticals' (CPRX) Loss Narrow in Q3? - Analyst Blog
11/12/2014 5:30:00 PM - Zacks.com


UCB to Sell Generics Business, Focus on Core Segments - Analyst Blog
11/10/2014 5:30:00 PM - Zacks.com


UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog
9/17/2014 5:40:00 PM - Zacks.com


Roche's (RHHBY) RoActemra Gets EU Approval for Early RA - Analyst Blog
9/9/2014 4:20:00 PM - Zacks.com


UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog
9/2/2014 3:45:00 PM - Zacks.com


UCB Files Patent Infringement Lawsuit vs. Actavis - Analyst Blog
8/28/2014 3:40:00 PM - Zacks.com


Drug Patent Expirations This Week: UCB, Roche's Genentech
8/8/2014 9:17:00 AM - Seeking Alpha